Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001005201-19-000093
Filing Date
2019-08-09
Accepted
2019-08-09 16:06:51
Documents
94
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a6302019-form10xq.htm 10-Q 1505015
2 EXHIBIT 31.1 exhibit311-2q2019.htm EX-31.1 12994
3 EXHIBIT 31.2 exhibit312-2q2019.htm EX-31.2 12862
4 EXHIBIT 32.1 exhibit321-2q2019.htm EX-32.1 6982
5 EXHIBIT 32.2 exhibit322-2q2019.htm EX-32.2 7026
  Complete submission text file 0001005201-19-000093.txt   8558946

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT asrt-20190630.xml EX-101.INS 1991021
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asrt-20190630.xsd EX-101.SCH 67054
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT asrt-20190630_cal.xml EX-101.CAL 100350
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT asrt-20190630_def.xml EX-101.DEF 326940
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asrt-20190630_lab.xml EX-101.LAB 776926
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asrt-20190630_pre.xml EX-101.PRE 482145
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Filer) CIK: 0001005201 (see all company filings)

EIN.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13111 | Film No.: 191013020
SIC: 2834 Pharmaceutical Preparations